fluoxetine has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jope, RS; Li, X; Polter, AM; Yang, S | 1 |
| Cao, Q; Shen, D; Xiong, X; Yang, H; Zhang, N; Zhang, Y; Zhao, P | 1 |
2 other study(ies) available for fluoxetine and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
| Article | Year |
|---|---|
Functional significance of glycogen synthase kinase-3 regulation by serotonin.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Chromones; Fear; Fluoxetine; Freezing Reaction, Cataleptic; Gene Knock-In Techniques; Glycogen Synthase Kinase 3; Hippocampus; Male; Mice; Mice, Inbred C57BL; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Agonists; Signal Transduction | 2012 |
Fluoxetine regulates glucose and lipid metabolism via the PI3K‑AKT signaling pathway in diabetic rats.
Topics: Animals; Cell Line; Chromones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fluoxetine; Gene Expression Regulation; Lipid Metabolism; Male; Morpholines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Streptozocin | 2020 |